검색
Bristol-Myers Squibb Co
BMY관심 목록에 추가
66.580USD
-0.370-0.55%
종가 08-28 16:00（ET）
136.02B시가총액
18.64P/E TTM
자세한 내용은 Bristol-Myers Squibb Co 회사
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Opdualag (nivolumab and relatlimab-rmbw), Breyanzi (lisocabtagene maraleucel), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), and Sotyktu (deucravacitinib). Its other growth products include Onureg, Inrebic, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension). Opdivo (nivolumab) is a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells.
Bristol-Myers Squibb Co 프로필
종목 코드 BMY
회사 이름Bristol-Myers Squibb Co
상장일Mar 17, 1980
CEOBoerner (Christopher S)
직원 수34100
유형Ordinary Share
회계 연도 종료Mar 17
주소Route 206 And Province Line Road
도시PRINCETON
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호08543
전화16092524621
웹사이트https://www.bms.com
종목 코드 BMY
상장일Mar 17, 1980
CEOBoerner (Christopher S)
Bristol-Myers Squibb Co의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Christopher S. (Chris) Boerner, Ph.D.
Dr. Christopher S. (Chris) Boerner, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
146.89K
+56.50%
Dr. Christopher S. (Chris) Boerner, Ph.D.
Dr. Christopher S. (Chris) Boerner, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
146.89K
+56.50%
Dr. Julia A. Haller, M.D.
Dr. Julia A. Haller, M.D.
Independent Director
Independent Director
34.08K
+60.04%
Dr. Julia A. Haller, M.D.
Dr. Julia A. Haller, M.D.
Independent Director
Independent Director
34.08K
+60.04%
Ms. Karin Shanahan
Ms. Karin Shanahan
Executive Vice President, Chief Supply Chain & Operations Officer , Member of the Leadership Team
Executive Vice President, Chief Supply Chain & Operations Officer , Member of the Leadership Team
28.79K
+5.61%
Ms. Karin Shanahan
Ms. Karin Shanahan
Executive Vice President, Chief Supply Chain & Operations Officer , Member of the Leadership Team
Executive Vice President, Chief Supply Chain & Operations Officer , Member of the Leadership Team
28.79K
+5.61%
Mr. Adam Lenkowsky
Mr. Adam Lenkowsky
Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team
Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team
28.48K
+2.00%
Mr. Adam Lenkowsky
Mr. Adam Lenkowsky
Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team
Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team
28.48K
+2.00%
Dr. Cristian Massacesi, M.D.
Dr. Cristian Massacesi, M.D.
Executive Vice President, Chief Medical Officer, Head of Development, Member of the Leadership Team
Executive Vice President, Chief Medical Officer, Head of Development, Member of the Leadership Team
25.00K
--
Dr. Cristian Massacesi, M.D.
Dr. Cristian Massacesi, M.D.
Executive Vice President, Chief Medical Officer, Head of Development, Member of the Leadership Team
Executive Vice President, Chief Medical Officer, Head of Development, Member of the Leadership Team
25.00K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Christopher S. (Chris) Boerner, Ph.D.
Dr. Christopher S. (Chris) Boerner, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
146.89K
+56.50%
Dr. Christopher S. (Chris) Boerner, Ph.D.
Dr. Christopher S. (Chris) Boerner, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
146.89K
+56.50%
Dr. Julia A. Haller, M.D.
Dr. Julia A. Haller, M.D.
Independent Director
Independent Director
34.08K
+60.04%
Dr. Julia A. Haller, M.D.
Dr. Julia A. Haller, M.D.
Independent Director
Independent Director
34.08K
+60.04%
Ms. Karin Shanahan
Ms. Karin Shanahan
Executive Vice President, Chief Supply Chain & Operations Officer , Member of the Leadership Team
Executive Vice President, Chief Supply Chain & Operations Officer , Member of the Leadership Team
28.79K
+5.61%
Ms. Karin Shanahan
Ms. Karin Shanahan
Executive Vice President, Chief Supply Chain & Operations Officer , Member of the Leadership Team
Executive Vice President, Chief Supply Chain & Operations Officer , Member of the Leadership Team
28.79K
+5.61%
자주 묻는 질문
Bristol-Myers Squibb Co의 상위 5대 주주는 누구인가요?
Bristol-Myers Squibb Co의 상위 5대 주주는 다음과 같습니다: Dr. Christopher S. (Chris) Boerner, Ph.D.
Bristol-Myers Squibb Co(BMY)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Bristol-Myers Squibb Co의 주식을 보유한 기관은 총 4176곳이며, 이들이 보유한 주식의 총 가치는 약 1.72B로 전체 발행 주식의 84.35%를 차지합니다. 이는 2025Q4 대비 -11351598.00 증가한 수치입니다.
Bristol-Myers Squibb Co의 최대 수익원은 무엇인가요?
2026Q1 기준, Bristol-Myers Squibb Co의 Eliquis 부문이 가장 높은 매출을 기록했으며, 금액은 4.48B로 전체 매출의 34.54%를 차지했습니다.